T cell infiltrate and outcome following resection of intermediate-grade primary neuroendocrine tumours and liver metastases

HPB - Tập 12 - Trang 674-683 - 2010
Steven C. Katz1,2,3, Charan Donkor3, Kristen Glasgow1, Venu G. Pillarisetty4, Mithat Gönen5, N. Joseph Espat1,2, David S. Klimstra6, Michael I. D'Angelica4, Peter J. Allen4, William Jarnagin3, Ronald P. DeMatteo4, Murray F. Brennan3, Laura H. Tang6
1Division of Surgical Oncology, Department of Surgery, Roger Williams Medical Center, Providence, RI, USA
2Department of Surgery, Boston University School of Medicine, Boston, MA, USA
3Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
4Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
5Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
6Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

Tài liệu tham khảo

Fahy, 2009, Synchronous hepatic metastases from colon cancer: changing treatment strategies and results of surgical intervention, Ann Surg Oncol, 16, 361, 10.1245/s10434-008-0217-3

Kulke, 2005, Advances in the treatment of neuroendocrine tumours, Curr Treat Options Oncol, 6, 397, 10.1007/s11864-005-0043-9

Modlin, 1997, An analysis of 8305 cases of carcinoid tumours, Cancer, 79, 813, 10.1002/(SICI)1097-0142(19970215)79:4<813::AID-CNCR19>3.0.CO;2-2

Oberg, 1989, Medical treatment of neuroendocrine gut and pancreatic tumours, Acta Oncol, 28, 425, 10.3109/02841868909111217

Chamberlain, 2000, Hepatic neuroendocrine metastases: does intervention alter outcomes?, J Am Coll Surg, 190, 432, 10.1016/S1072-7515(00)00222-2

Cho, 2008, Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms, Cancer, 113, 126, 10.1002/cncr.23523

Sarmiento, 2003, Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival, J Am Coll Surg, 197, 29, 10.1016/S1072-7515(03)00230-8

Touzios, 2005, Neuroendocrine hepatic metastases: does aggressive management improve survival?, Ann Surg, 241, 776, 10.1097/01.sla.0000161981.58631.ab

Bilimoria, 2008, Prognostic score predicting survival after resection of pancreatic neuroendocrine tumours: analysis of 3851 patients, Ann Surg, 247, 490, 10.1097/SLA.0b013e31815b9cae

Ferrone, 2007, Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified?, J Clin Oncol, 25, 5609, 10.1200/JCO.2007.12.9809

Gullo, 2003, Non-functioning pancreatic endocrine tumours: a multicentre clinical study, Am J Gastroenterol, 98, 2435, 10.1111/j.1572-0241.2003.07704.x

Hochwald, 2002, Prognostic factors in pancreatic endocrine neoplasms: an analysis of 136 cases with a proposal for low-grade and intermediate-grade groups, J Clin Oncol, 20, 2633, 10.1200/JCO.2002.10.030

Phan, 1998, Surgical experience with pancreatic and peripancreatic neuroendocrine tumours: review of 125 patients, J Gastrointest Surg, 2, 473, 10.1016/S1091-255X(98)80039-5

Vagefi, 2007, Evolving patterns in the detection and outcomes of pancreatic neuroendocrine neoplasms: the Massachusetts General Hospital experience from 1977 to 2005, Arch Surg, 142, 347, 10.1001/archsurg.142.4.347

Reidy, 2009, Treatment of advanced disease in patients with well-differentiated neuroendocrine tumours, Nat Clin Pract Oncol, 6, 143, 10.1038/ncponc1326

Kobayashi, 2007, FoxP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis, Clin Cancer Res, 13, 902, 10.1158/1078-0432.CCR-06-2363

Sasaki, 2008, Prognostic value of tumour-infiltrating FoxP3+ regulatory T cells in patients with hepatocellular carcinoma, Eur J Surg Oncol, 34, 173, 10.1016/j.ejso.2007.08.008

Galon, 2006, Type, density, and location of immune cells within human colorectal tumours predict clinical outcome, Science, 313, 1960, 10.1126/science.1129139

Galon, 2007, The adaptive immunologic microenvironment in colorectal cancer: a novel perspective, Cancer Res, 67, 1883, 10.1158/0008-5472.CAN-06-4806

Katz, 2009, T cell infiltrate predicts longterm survival following resection of colorectal cancer liver metastases, Ann Surg Oncol, 16, 2524, 10.1245/s10434-009-0585-3

Pagès, 2005, Effector memory T cells, early metastasis, and survival in colorectal cancer, N Engl J Med, 353, 2654, 10.1056/NEJMoa051424

Zhang, 2003, Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer, N Engl J Med, 348, 203, 10.1056/NEJMoa020177

Cohen, 2008, Expression of P53, P27 and KI-67 in colorectal cancer patients of various ethnic origins: clinical and tissue microarray based analysis, J Surg Oncol, 97, 416, 10.1002/jso.20989

Hori, 2003, Control of regulatory T cell development by the transcription factor FoxP3, Science, 299, 1057, 10.1126/science.1079490

Ryschich, 2003, Expression of HLA class I/II antigens and T cell immune response in human neuroendocrine tumours of the pancreas, Tissue Antigens, 62, 48, 10.1034/j.1399-0039.2003.00075.x

Fu, 2007, Increased regulatory T cells correlate with CD8T cell impairment and poor survival in hepatocellular carcinoma patients, Gastroenterology, 132, 2328, 10.1053/j.gastro.2007.03.102

Thông tin
Thông tin xuất bản

HPB

Tập 12

674-683

Thông tin tác giả